Table of contents

Key facts

Active substance
The whole range of unmanipulated autologous mononuclear cells derived from human umbilical cord blood (Hau-UCB-mnc)
Therapeutic area
Neonatology-Paediatric Intensive Care
Decision number
PIP number
Pharmaceutical form(s)
Suspension for infusion
Condition(s) / indication(s)
Treatment of periventricular leukomalacia
Route(s) of administration
Intravenous use
Contact for public enquiries
BrainRepair UG (haftungsbeschränkt)

E-mail: arne.jensen@brainrepair.eu​​​​​​​
Tel. +49 2345881960

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)


How useful was this page?

Add your rating